抗凝固的新策略:XI因子抑制剂
Maria Cristina Vedovati1, Cecilia Becattini1, Giancarlo Agnelli2
1Internal, Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Piazzale Giorgio Menghini, 3, Perugia 06129, Italy.
European journal of internal medicine
|August 6, 2023
概括
新的XI因子抑制剂为预防血液凝块提供了一种有前途的替代药物,可以替代直接口服抗凝剂 (DOACs). 这些新型药物旨在降低血栓形成风险而不会增加出血,挑战了抗凝治疗的传统观点.
科学领域:
- 药理学和血栓瘤研究研究
- 开发针对特定凝固因子的新型抗凝剂.
背景情况:
- 直接口服抗凝剂 (DOAC) 是对心房和静脉血栓塞栓症 (VTE) 的一线治疗方法,比维生素K对抗剂 (VKA) 提供更好的疗效和安全性.
- DOAC有其局限性,包括缺乏特定患者群体的益处 (例如,机械,抗脂综合征) 和有关胃肠道出血的担忧.
- 建议开发XI因子和XII因子抑制剂,以克服DOAC的局限性,并扩大抗凝剂的临床效用.
研究的目的:
- 提供关于XI因子抑制剂的推理,药理性质和初步临床发现的最新信息.
- 探索XI因子抑制剂在脱离血静与血栓形成方面的潜力,解决长期存在的出血问题,作为抗凝药不可避免的副作用.
主要方法:
- 关于XI因子在血液静止和血栓形成中的作用的新兴数据的审查.
- 开发XI因子抑制剂的药理学特征分析.
- 从研究研究XI因子抑制剂的初步临床发现的评估.
主要成果:
- 因子XI在生理血液静止中起小作用,但在血栓形成中起重要作用.
- XI因子抑制剂旨在选择性地抑制血栓形成,同时保持正常的血静,可能降低出血风险.
- 初步的临床数据表明,XI因子抑制剂的潜在疗效和改善的安全性.
结论:
- XI因子抑制剂在抗凝血中代表了一种新的治疗策略,可能提供更有利的疗效安全平衡.
- 这些药物挑战了出血是抗凝固药治疗不可避免的后果的教条.
- 需要进一步的研究和临床试验,以充分确定XI因子抑制剂在各种临床环境中的作用.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
753
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
753
01:30Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
563
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
563
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10